Akcije

Archive of Oncology
kako citirati ovaj članak
podeli ovaj članak

Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:3
  • preuzimanja u poslednjih 30 dana:2

Sadržaj

članak: 4 od 4  
Back povratak na rezultate
2019, vol. 25, br. 2, str. 25-27
Long-term survival of a patient with locally advanced hilar cholangiocarcinoma (Klatskin tumor): A case report and review on high level evidence
(naslov ne postoji na srpskom)
aIran University of Medical Sciences, Firoozgar Clinical Research Development Center (FCRDC), Department of Surgery, Tehran, Iran
bIran University of Medical Sciences, Firoozgar Clinical Research Development Center (FCRDC), Department of Interventional Radiology, Tehran, Iran
cIran University of Medical Sciences, Firoozgar Clinical Research Development Center (FCRDC), Department of Pathology, Tehran, Iran
dIran University of Medical Sciences, Student Research Committee, Tehran, Iran

e-adresaomid_hadi_zadeh@yahoo.com
Ključne reči: Cholangiocarcinoma; Survival; Stents
Sažetak
(ne postoji na srpskom)
Cholangiocarcinoma, malignant tumor of epithelial cells of bile ducts has poor overall survival and prognosis. We report a case of non-resectable cholangiocarcinoma with a 57-month survival after incomplete R2 surgical margin resection of the tumor. A 52-year old man with generalized itching, jaundice, brownish urine, mild abdominal pain and weight loss of 8 kg in last two months presented. Imaging and surgical workups showed hilar cholangiocarcinoma (Klatskin tumor). Along with incomplete R2 margin resection we performed stent embedding and post-operative adjuvant chemotherapy. Based on current literature data there is no superiority of adjuvant chemotherapy after complete R0 resection compared to incomplete R2 resection. However, it seems that partial resection along with stent embedding and applied adjuvant chemotherapy in cases of locally advanced non-resectable cholangiocarcinoma may increase survival rate.
Reference
Bird, N.T.E., McKenna, A., Dodd, J., Poston, G., Jones, R., Malik, H. (2018) Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinoma. British Journal of Surgery, 105(11): 1408-1416
Blechacz, B., Gores, G.J. (2008) Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment. Hepatology, 48(1): 308-321
Carriaga, M.T., Henson, D.E. (1995) Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer, 75(S1): 171-190
Deoliveira, M.L., Cunningham, S.C., Cameron, J.L., Kamangar, F., Winter, J.M., Lillemoe, K.D., Schulick, R.D. (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Annals of Surgery, 245(5): 755-762
Hirschfield, G.M., Karlsen, T.H., Lindor, K.D., Adams, D.H. (2013) Primary sclerosing cholangitis. Lancet, 382(9904): 60096-60099
Jarnagin, W.R., Fong, Y., Dematteo, R.P., Gonen, M., Burke, E.C., Bodniewicz, J., Blumgart, L.H. (2001) Staging, Resectability, and Outcome in 225 Patients with Hilar Cholangiocarcinoma. Annals of Surgery, 234(4):507-519
Kahaleh, M., Mishra, R., Shami, V.M., Northup, P.G., Berg, C.L., Bashlor, P., Yeaton, P. (2008) Unresectable Cholangiocarcinoma: Comparison of Survival in Biliary Stenting Alone Versus Stenting with Photodynamic Therapy. Clinical Gastroenterology and Hepatology, 6(3):290-297
Khan, S.A., Taylor-Robinson, S.D., Toledano, M.B., Beck, A., Elliott, P., Thomas, H.C. (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. Journal of Hepatology, 37(6): 297-297
Khan, S.A., Thomas, H.C., Davidson, B.R., Taylor-Robinson, S.D. (2005) Cholangiocarcinoma. Lancet, 366(9493): 1303-1314
Li, M., Bi, X., Li, Z., Huang, Z., Han, Y., Zhao, J., Zhao, H., Cai, J. (2016) Impaction of surgical margin status on the survival outcome after surgical resection of intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Journal of Surgical Research, 203(1): 163-173
Mavros, M.N., Economopoulos, K.P., Alexiou, V.G., Pawlik, T.M. (2014) Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: Systematic review and meta-analysis. JAMA Surgery, 149(6): 565-565
Mihalache, F., Tantau, M., Diaconu, B., Acalovschi, M. (2010) Survival and quality of life of cholangiocarcinoma patients: A prospective study over a 4 year period. Journal of Gastrointestinal & Liver Diseases, (3): 19-19
Murakami, Y., Uemura, K., Sudo, T., Hayashidani, Y., Hashimoto, Y., Nakamura, H., Nakashima, A., Sueda, T. (2009) Gemcitabine-Based Adjuvant Chemotherapy Improves Survival After Aggressive Surgery for Hilar Cholangiocarcinoma. Journal of Gastrointestinal Surgery, 13(8): 1470-1479
Nathan, H., Pawlik, T.M., Wolfgang, C.L., Choti, M.A., Cameron, J.L., Schulick, R.D. (2007) Trends in Survival after Surgery for Cholangiocarcinoma: A 30-Year Population-Based SEER Database Analysis. Journal of Gastrointestinal Surgery, 11(11): 1488-1497
Olnes, M.J., Erlich, R. (2004) A Review and Update on Cholangiocarcinoma. Oncology, 66(3): 167-179
Palmer, W.C., Patel, T. (2012) Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. Journal of Hepatology, 57(1): 69-76
Parker, S.L., Tong, T., Bolden, S., Wingo, P.A. (1997) Cancer statistics, 1997. CA: A cancer journal for clinicians, 47(1): 5-27
Ren, H., Yu, T., Liu, C., Li, Y. (2011) Diabetes mellitus and increased risk of biliary tract cancer: Systematic review and meta-analysis. Cancer Causes & Control, 22(6): 837-847
Shaib, Y., El-Serag, H. (2004) The Epidemiology of Cholangiocarcinoma. Seminars in Liver Disease, 24(02):115-125
Tang, H., Lu, W., Li, B., Meng, X., Dong, J. (2016) Influence of surgical margins on overall survival after resection of intrahepatic cholangiocarcinoma: A meta-analysis. Medicine, 95(35): e4621-e4621
Tsao, J.I., Nimura, Y., Kamiya, J., Hayakawa, N., Kondo, S., Nagino, M., Dugan, J.M. (2000) Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Annals of Surgery, 232(2):166-174
Tyson, G.L., El-Serag, H.B. (2011) Risk factors for cholangiocarcinoma. Hepatology, 54(1): 173-184
Wellner, U.F., Shen, Y., Keck, T., Jin, W., Xu, Z.W. (2017) The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: A meta-analysis for the 5-year survival. Surgery Today, 47(3): 271-279
Zhou, Y., Liu, S., Wu, L., Wan, T. (2017) Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors. Asian Journal of Surgery, 40(2): 129-138
 

O članku

jezik rada: engleski
vrsta rada: prikaz slučaja
DOI: 10.2298/AOO190220004V
objavljen u SCIndeksu: 29.07.2019.
metod recenzije: jednostruko anoniman
Creative Commons License 4.0

Povezani članci

Nema povezanih članaka